Type 2 Diabetes

Spot check your memory for these disease details.

Trade names often mask the essential nature of a medication, but some of the new agents that treat type 2 diabetes take it to a new level. Here, 5 chances to see what you know.

Obese patients looking to lose weight or treat type 2 diabetes have often turned to gastric bypass or other stomach-shrinking surgeries, which have produced favorable results, decreasing cancer risks.

Evidence is mounting that links insulin deficiency and insulin resistance to mediation of Alzheimer disease-type neurodegeneration. Get the highlights in these 9 slides.

Hospital staff or other physicians would never consider changing a chemo or dialysis order. But when it comes to insulin, it’s open season. This needs to stop.

Not all patients with type 2 diabetes respond equally to GLP-1 receptor agonists. Results of a recent study suggest what to look for before you write that next Rx.

Since June of 2014, the US FDA has approved a number of drugs for a variety of endocrine-related diseases. Here are 10 of them.

John is an active older man whose A1c has gone from 6.8% to 7.6% since his last follow-up visit. He refuses to get involved in any “needle business.” What’s next?

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reported that one in 10 American adults had some level of chronic kidney disease (CKD), and that kidney disease is the 9th leading cause of death in the US.

Exenatide, dulaglitide, albiglutide, liraglutide. Can you answer these four questions on the facts about the glucagon-like receptor-1 receptor agonists?

The American Diabetes Association has adopted the 2013 ACC/AHA cholesterol guidelines in its 2015 Standards of Care -- but not entirely.

The 3 FDA-approved sodium glucose co-transporter 2 inhibitors remain under close post-marketing scrutiny. These 7 slides distill for you all the cancer risk information to date.

The Food and Drug Administration has approved a new medication to improve glycemic control in adults with type 2 diabetes.

Pre-surgical weight loss in obese patients with type 2 diabetes reduces perioperative risk. The dual benefits of GLP-1 agonists offer promise to this hard-to-treat population.

Regulation of glucose homeostasis by the kidney is impaired in persons with type 2 diabetes. Find out what you know about this renal dysfunction and the role of SGLT2 inhibition in reducing hyperglycemia.

The "inverted champagne bottle" appearance of the distal leg is a specific finding associated with this condition. Lipodermatosclerosis usually occurs in patients with long-standing venous insufficiency.

The incidence and mortality of pancreatic adenocarcinoma, the fourth leading cause of cancer deaths in the United States, are both on the rise. Globally, the disease is responsible for 227,000 deaths annually. Researchers from the National Taiwan University College of Medicine recently published a meta-analysis that demonstrated a dose-response relationship between fasting blood glucose levels and pancreatic cancer risk. They also examined the link between prediabetes and pancreatic cancer risk.

Endo Tools, Endo Pubs, Glooko--just a few of the mobile apps described here, all designed specifically for the clinical endocrinologist.

Researchers in Scotland have shown that while diabetes is a growing problem for that country's population, patients diagnosed with the condition are living considerably longer than they would have in the past. This is particularly true for patients diagnosed with type 1 diabetes.

With a new year comes New Year's resolutions, many of which involve getting healthy in the year ahead. A recent study has shown that by keeping those resolutions people can not only lose the weight they want but also avoid other health issues like diabetes.

The investigational LX4211 may one day fill a need for these patients who are unable to eliminate a lot of glucose in urine and who respond poorly to selective SGLT2 inhibitors.

Clue: What do domperidone and metoclopramide have in common?

Low total serum testosterone was independently associated with greater carotid intima media thickening and endothelial dysfunction but not with atherosclerotic plaques.

The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.

Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.